How Do They Test for Sleep Apnea at Home?

Home sleep apnea testing uses a small portable device, typically worn on your chest and finger with a nasal sensor, to record your breathing patterns, blood oxygen levels, and body position while you sleep in your own bed. The American Academy of Sleep Medicine recognizes these tests as an alternative to overnight laboratory monitoring for adults who show signs of moderate to severe obstructive sleep apnea (OSA) and have no complicating medical conditions.¹ The process is simpler than most people expect, but the details matter more than the marketing materials suggest.

What the Device Actually Measures

The most commonly prescribed home test is a Type 3 portable monitor, which accounts for roughly two-thirds of all FDA-cleared home sleep apnea testing devices.² A Type 3 device records at least four channels of data: airflow through the nose (using a nasal cannula or pressure transducer), blood oxygen saturation (via a finger clip called a pulse oximeter), respiratory effort (measured by elastic belts around your chest and abdomen), and heart rate. Some devices add body position sensors and snoring microphones.

Type 2 devices are more elaborate. They include all the channels of a full in-lab sleep study, including brainwave monitoring through scalp electrodes, which lets them detect when you’re actually asleep versus lying awake. These make up about a fifth of FDA-cleared devices.² At the other end, Type 4 devices measure only one or two channels, often just oxygen levels and heart rate. A notable example is the WatchPAT system, which sits on your wrist and fingertip and detects breathing disruptions by measuring changes in the tone of your finger’s blood vessels rather than airflow directly.³ The idea behind peripheral arterial tonometry is that when your airway collapses during an apnea event, it triggers changes in your nervous system that show up as measurable shifts in the blood flow to your finger.

How the Night Itself Works

In most cases, you pick up the device from a sleep clinic, hospital, or have it shipped to you. A technician or instructional video walks you through setup. The typical routine looks like this:

Nasal cannula: a thin tube rests just inside or below your nostrils to measure airflow.
Chest and belly belts: elastic bands detect the rise and fall of your breathing effort.
Finger clip: a pulse oximeter tracks your oxygen saturation and heart rate.
Recording unit: a small box, usually clipped to your chest belt or resting nearby, stores all the data.

You press a button to start recording when you go to bed, then press it again when you wake up. The device records everything overnight, and you return it the next day or ship it back. A sleep specialist or trained technician then downloads and reviews the data. The whole experience is far less intrusive than an in-lab study, where you’d be connected to roughly two dozen sensors while sleeping in a monitored room.

Failure rates are generally low but not zero. One study found that about 2% of home tests needed to be repeated because the recording didn’t capture at least four hours of usable oxygen and airflow data, with oximeter signal loss being the most common culprit.⁴ Other research has put the overall failure rate higher, around 15% when device malfunctions and patient-related issues like removing sensors during sleep are combined, with the majority of failures being patient-related rather than equipment-related.⁵ If a sensor pops off your finger or the nasal cannula shifts while you toss and turn, that portion of the data becomes unusable.

Who Should and Should Not Use a Home Test

Home sleep testing is designed for a specific patient profile: adults with a high clinical suspicion of moderate to severe obstructive sleep apnea and no major complicating conditions. The AASM’s position is clear that testing should be ordered by a medical provider based on your history and an examination, not used as a general screening tool for people without symptoms.¹

Several groups are poor candidates for home testing. If you have moderate to severe lung disease, neuromuscular conditions, or heart failure, these conditions can affect breathing patterns in ways that confuse the device’s interpretation or require the more detailed monitoring of an in-lab study.⁶ If your resting oxygen levels are already low or you use supplemental oxygen, a home test may not accurately capture your breathing events. People suspected of having central sleep apnea, where the brain intermittently stops sending breathing signals rather than the airway physically collapsing, have traditionally needed in-lab monitoring, though newer research is pushing this boundary as described below.

Children are another important exception. The AASM has stated that home sleep apnea testing is not recommended for diagnosing OSA in children.⁷ Pediatric sleep apnea involves different thresholds, different causes (enlarged tonsils and adenoids rather than tissue collapse from weight and anatomy), and different treatment decisions that require the more granular data a lab study provides. That said, preliminary research has shown that adding brainwave monitoring (EEG) to home devices improves their accuracy in children, particularly for mild cases and younger kids.⁸ This remains a research area rather than standard practice.

How Accurate Are the Results

Home tests are quite good at confirming sleep apnea when it’s present, but they have a built-in tendency to underestimate how severe it is. The sensitivity of home testing, meaning how often it correctly identifies someone who has OSA, runs in the mid-to-high 90% range for detecting any level of the condition. One comparison study found sensitivity of about 95% and overall accuracy of 91% for diagnosing OSA against a full in-lab study.⁹ A separate validation of Type 2 home devices found similar sensitivity of 97% at the mildest diagnostic threshold and 95% at the moderate threshold.¹⁰

The specificity, meaning how well the test correctly identifies people who do not have sleep apnea, is consistently lower. Both studies cited above found specificity in the 56-76% range, which means a meaningful number of people without clinically significant apnea could receive a borderline positive result. In practice, this is less of a concern than it sounds, because home tests are primarily ordered for people already suspected of having the condition. The bigger clinical worry runs in the other direction.

The Underestimation Problem

The core metric in sleep apnea diagnosis is how many times per hour your breathing stops or becomes dangerously shallow. In a lab, this is calculated as the apnea-hypopnea index, or AHI, using actual measured sleep time. The crucial difference with most home devices is that they cannot tell when you are asleep versus lying awake, because they lack brainwave sensors. Instead, they divide the number of breathing events by the total recording time, which includes any minutes you spent reading, staring at the ceiling, or getting up for the bathroom. This produces a number called the respiratory event index, or REI, which is almost always lower than the true AHI.

Research consistently shows that the REI significantly underestimates severity compared to the AHI across all severity groups.¹¹ One analysis simulated what would happen if in-lab sleep studies were rescored using total time in bed rather than measured sleep time, mimicking what a home device does. The results were striking: roughly a quarter of all OSA patients would be reclassified as having milder disease or none at all. Among people with moderate OSA, about 40% would be downgraded to mild. Among those with severe OSA, 36% would be downgraded to moderate.¹² A separate study confirmed the basic mechanism: Type 3 home tests tend to overestimate how long you were asleep, which dilutes the severity score.¹³

This underestimation matters for treatment decisions. If your true severity is moderate but the home test reads as mild, you and your doctor might delay treatment or pursue a less aggressive option. Sleep specialists who review home test results are generally aware of this limitation and may factor it into their recommendations, but the gap is worth understanding if you’re the patient reviewing your own numbers.

How the Data Gets Scored

After you return the device, the raw data goes through both automated software analysis and review by a sleep technician or physician. The automated scoring algorithms have improved substantially. Across international sleep centers, the difference between automated and manual scoring has been found to be small, generally within a couple of events per hour.¹⁴ A separate comparison found that automated scoring agreed with manual expert scoring more than 90% of the time when classifying patients into mild, moderate, or severe categories.¹⁵

The weak spots tend to appear right at the boundaries between severity categories. That same study found that 11-21% of recordings near the border between mild and moderate sleep apnea were misclassified by automated scoring. Automatic systems also tended to overestimate the duration of individual breathing events, which doesn’t change the diagnosis but can affect how confident a clinician feels about the result. Most practices use automated scoring as a first pass and have a trained human review flagged or borderline cases.

Distinguishing Types of Sleep Apnea at Home

A common concern is whether home devices can tell the difference between obstructive sleep apnea, where your airway physically collapses, and central sleep apnea, where your brain temporarily stops telling your muscles to breathe. This distinction matters because the treatments differ. Traditional Type 3 home devices with nasal airflow sensors can actually make this distinction reasonably well. Technicians classify events based on whether respiratory effort continues during an apnea (obstructive) or stops entirely (central). Research in heart failure patients found that home devices showed similar detection rates for both obstructive and central events compared to in-lab monitoring.¹⁶

The WatchPAT system takes a different approach. It distinguishes central from obstructive events by comparing chest wall movement data from a built-in accelerometer with patterns in the finger’s blood vessel signal. During a central event, certain waveform features persist regardless of breathing effort, while during an obstructive event, the pressure changes from struggling to breathe against a closed airway alter those waveform features in a characteristic way.¹⁷ This is encouraging for expanding home testing to more complex patients, though guidelines still recommend in-lab studies when central sleep apnea is strongly suspected.

What Happens After a Positive Home Test

If your home test confirms OSA, you do not necessarily need to go to a sleep lab for a second study to calibrate treatment. The traditional pathway involved an in-lab “titration night” where a technician gradually adjusted the pressure on a CPAP machine while you slept, finding the exact setting that kept your airway open. Today, the AASM recommends that treatment can be started at home using an auto-adjusting positive airway pressure (APAP) machine, which finds the right pressure on its own night after night.¹⁸

Research comparing the two approaches found equivalent results: patients diagnosed by home testing who went straight to auto-adjusting pressure therapy at home used their machines just as consistently and reported the same improvement in daytime sleepiness as those who went through the traditional lab titration route.¹⁹ A systematic review and meta-analysis confirmed that starting treatment at home produced equivalent outcomes compared to the lab-based approach.²⁰ This means many patients can go from suspicion to diagnosis to treatment without ever sleeping in a lab.

The important caveat: a negative or inconclusive home test in someone who strongly appears to have sleep apnea does not rule out the condition. Because of the underestimation tendency described above, the AASM’s position is that if clinical suspicion remains high after a negative home test, a full in-lab polysomnography should follow.¹

Cost and Access

One of the driving forces behind home testing’s growth has been the push from insurance companies and the practical appeal of a less expensive diagnostic path.²¹ From an insurance perspective, the home pathway costs less per patient. One economic evaluation found that total costs from the payer’s perspective were about $265 lower per patient for home-based diagnosis compared to lab-based diagnosis.²² The savings are real but modest when you look at the full picture, because the total costs on both sides included follow-up care and treatment, not just the test itself.

Interestingly, the economics look different from the provider’s perspective. That same study found that the costs for providers were actually comparable between the two approaches, and sleep centers running home testing programs operated at a financial loss while in-lab testing generated a modest operating margin.²² This creates an awkward incentive structure where insurers push for home testing, patients prefer it for convenience, but sleep practices may struggle financially to offer it. Older cost-utility analyses have also found that while home testing is cheaper, full lab polysomnography provides somewhat more reliable results, and the added cost per unit of health benefit is within the range society typically considers worthwhile.²³

Consumer Wearables and the Next Generation

Smartwatches and fitness trackers are increasingly marketing sleep apnea detection features, which raises the question of whether consumer devices might eventually replace clinical home tests. Early validation studies are cautiously encouraging. One study of a smartwatch using only the optical heart rate sensor on the back of the device (measuring blood flow through the skin) found about 88% accuracy, 90% sensitivity, and 86% specificity for detecting moderate-to-severe OSA compared to a clinical home sleep test device.²⁴

Those numbers are promising for screening, meaning flagging people who should get a proper diagnostic test. They are not yet strong enough for diagnosis. A screening tool that misses one in ten people with moderate-to-severe sleep apnea and falsely flags about one in seven people without it creates a lot of unnecessary follow-up and missed cases. For now, consumer devices sit in a complementary role: useful for raising awareness and motivating a conversation with your doctor, but not a substitute for clinical testing.

The regulatory landscape for home testing devices is more rigorous than many patients realize. FDA-cleared devices must meet international safety and quality standards covering electromagnetic compatibility, usability in a home environment, and biocompatibility of any materials that contact your skin.²⁵ Consumer wearables that market sleep apnea features without FDA clearance for diagnosis operate in a grayer zone, and the gap between “wellness feature” and “diagnostic tool” is meaningful when your health decisions depend on the result.

1
PubMed Central. Clinical Use of a Home Sleep Apnea Test: An Updated American Academy of Sleep Medicine Position Statement
2
PubMed Central. FDA-cleared home sleep apnea testing devices
3
PubMed Central. Accuracy of peripheral arterial tonometry in the diagnosis of obstructive sleep apnea
4
PubMed Central. Agreement between Results of Home Sleep Testing for Obstructive Sleep Apnea with and without a Sleep Specialist
5
Journal of Sleep Disorders: Treatment and Care. Predicting Technical Success in Home Sleep Apnea Test
6
The Journal of the American Board of Family Medicine. Home Sleep Tests for Obstructive Sleep Apnea (OSA)
7
PubMed Central. American Academy of Sleep Medicine Position Paper for the Use of a Home Sleep Apnea Test for the Diagnosis of OSA in Children
8
PubMed Central. Accuracy and acceptability of home sleep apnea testing with electroencephalography compared to in-lab polysomnography for the diagnosis of obstructive sleep apnea in children
9
PubMed Central. Comparison of a home sleep test with in-laboratory polysomnography in the diagnosis of obstructive sleep apnea syndrome
10
PubMed. Home-based diagnosis of obstructive sleep apnea by polysomnography type 2: accuracy, reliability, and feasibility
11
PubMed Central. Respiratory event index underestimates severity of sleep apnea compared to apnea-hypopnea index
12
PubMed Central. Potential Underestimation of Sleep Apnea Severity by At-Home Kits: Rescoring In-Laboratory Polysomnography Without Sleep Staging
13
PubMed Central. Effect of Manual Editing of Total Recording Time: Implications for Home Sleep Apnea Testing
14
PubMed Central. Home sleep apnea testing: comparison of manual and automated scoring across international sleep centers
15
PubMed. Comparing manual and automatic scoring of sleep monitoring data from portable polygraphy
16
PubMed Central. Home sleep apnea testing of adults with chronic heart failure
17
PubMed Central. Home Sleep Apnoea Testing: Advances, Challenges and Considerations in Heart Failure
18
PubMed Central. Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline
19
PubMed Central. Auto-adjusting positive airway pressure treatment for sleep apnea diagnosed by home sleep testing
20
PubMed Central. Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment
21
PubMed. In-home testing for obstructive sleep apnea
22
PubMed Central. An Economic Evaluation of Home Versus Laboratory-Based Diagnosis of Obstructive Sleep Apnea
23
PubMed. Cost-utility of three approaches to the diagnosis of sleep apnea: polysomnography, home testing, and empirical therapy
24
PubMed Central. A Single-Center Validation of the Accuracy of a Photoplethysmography-Based Smartwatch for Screening Obstructive Sleep Apnea
25
npj Digital Medicine. FDA-cleared home sleep apnea testing devices